In a patient with markedly elevated troponin I and inferolateral wall ischemia on electrocardiogram, what acute cardiac medications should be administered pending definitive reperfusion therapy?

Immediate Cardiac Medications for Inferolateral STEMI

Administer aspirin 162-325 mg (chewed or IV if unable to swallow), a potent P2Y12 inhibitor (ticagrelor 180 mg loading dose or prasugrel 60 mg if PCI planned, or clopidogrel 300-600 mg if these unavailable), and anticoagulation with either enoxaparin IV followed by subcutaneous (preferred) or unfractionated heparin as weight-adjusted IV bolus plus infusion 1.

Antiplatelet Therapy (Highest Priority)

Dual antiplatelet therapy (DAPT) is the cornerstone of acute management:

• Aspirin: 162-325 mg oral (chewed for faster absorption) or IV if patient cannot swallow. Continue 75-100 mg daily indefinitely 1, 2, 1.

• P2Y12 Inhibitor (choose based on reperfusion strategy):

  • Ticagrelor 180 mg loading dose (then 90 mg twice daily) - preferred for all moderate-to-high risk patients regardless of initial strategy 3
  • Prasugrel 60 mg loading dose (then 10 mg daily) - preferred if primary PCI is planned and no contraindications (prior stroke/TIA, age ≥75 years, weight <60 kg) 1
  • Clopidogrel 300-600 mg loading dose (then 75 mg daily) - if ticagrelor/prasugrel unavailable or contraindicated 1, 2, 1

The 2017 ESC guidelines strongly recommend potent P2Y12 inhibitors over clopidogrel for STEMI, as they provide faster and more consistent platelet inhibition 1.

Anticoagulation (Mandatory)

Select one anticoagulant based on reperfusion strategy:

• Enoxaparin: IV bolus followed by subcutaneous dosing - preferred over UFH for both fibrinolysis and PCI 1
• Unfractionated heparin (UFH): Weight-adjusted IV bolus followed by infusion 1
• Bivalirudin: Alternative if high bleeding risk, particularly for primary PCI 4

Critical caveat: Fondaparinux is contraindicated for primary PCI 1.

Continue anticoagulation until revascularization or for duration of hospitalization (up to 8 days) 1.

Additional Acute Medications

Symptom Relief & Hemodynamic Support

• Nitroglycerin: Sublingual or IV if systolic BP >90 mmHg and no contraindications (inferior MI with RV involvement, recent phosphodiesterase inhibitor use). Helps relieve ischemic pain and reduce preload 1.

• Morphine: May be considered for severe dyspnea/anxiety in pulmonary edema, but use cautiously - concerns exist about safety (nausea, respiratory depression) 1. Not for routine use.

• Oxygen: Only if SaO2 <90% - target saturation >95%. Routine oxygen is NOT recommended if saturation adequate 1.

Beta-Blockers

Oral beta-blockers should be initiated within 24 hours once hemodynamically stable 1, 2. However, IV beta-blockers are contraindicated in the acute phase if patient has:

• Hypotension
• Acute heart failure
• AV block or severe bradycardia
• Cardiogenic shock 1, 2

Given inferolateral ischemia, assess carefully for right ventricular involvement before any beta-blocker administration.

ACE Inhibitors

Start as soon as hemodynamically stable if evidence of LV dysfunction (LVEF <40%) or heart failure 1. For inferior MI, ensure adequate preload before initiating.

Management of Complications

If signs of heart failure/pulmonary congestion develop:

• Loop diuretics: Furosemide 20-40 mg IV, repeat as needed 1
• IV nitrates: If SBP >90 mmHg 1
• ACE inhibitor/ARB: Once stabilized 1

If hypotension/cardiogenic shock:

• Identify mechanism (hypovolemia, RV infarction, mechanical complication)
• Consider inotropic support only if refractory to standard treatment 1
• Urgent invasive hemodynamic assessment and revascularization 1

Critical Timing Considerations

The most important intervention is arranging immediate reperfusion - either:

• Primary PCI within 120 minutes of first medical contact (90 minutes if large anterior infarction in patient <75 years presenting within 2 hours) 1
• Fibrinolysis within 30 minutes if PCI cannot be achieved in time 1

All medications listed are adjunctive to definitive reperfusion therapy, which directly impacts mortality and morbidity.

Common Pitfalls to Avoid

1. Do not delay reperfusion to optimize medical therapy - medications should be given en route to catheterization laboratory
2. Avoid IV beta-blockers in acute phase - associated with increased mortality in unstable patients 2
3. Do not use fondaparinux if primary PCI planned 1
4. Assess for RV involvement in inferior MI before giving nitrates, diuretics, or ACE inhibitors - these can precipitate severe hypotension
5. Do not give prasugrel if coronary anatomy unknown or if prior stroke/TIA 3
6. Avoid routine oxygen if saturation adequate - may be harmful 1